Kirkland & Ellis advised Bristol Myers Squibb on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters. Bristol...
Bristol Myers Squibb’s $13 Billion Bond Offering
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
WeWork’s Comprehensive Restructuring of Capital Structure
Kirkland represented WeWork, Davis Polk represented an ad hoc group of unsecured noteholders, and Weil represented SoftBank. WeWork Inc. (NYSE: WE) announced a comprehensive restructuring of its...
Eli Lilly’s $487 Million Acquisition of Akouos
Kirkland & Ellis represented Lilly, while Wilmer Cutler Pickering Hale and Dorr represented Akouos in the transaction. Eli Lilly and Company (NYSE: LLY) announced its acquisition...
Lemonade’s Acquisition of Metromile
Latham & Watkins represented Lemonade in the transaction, while Kirkland & Ellis advised Metromile. Lemonade (NYSE: LMND), the insurance company powered by AI and social good, and...